112 related articles for article (PubMed ID: 19578206)
1. Detection of tolerance against human chorionic gonadotropin at malignant and benign tumors of female reproduction system.
Akhvlediani L; Nagervadze M; Dumbadze G
Georgian Med News; 2009 Jun; (171):20-4. PubMed ID: 19578206
[TBL] [Abstract][Full Text] [Related]
2. Preliminary therapeutic and localization studies with human chorionic gonadotrophin.
Bagshawe KD; Searle F; Lewis J; Brown P; Keep P
Cancer Res; 1980 Aug; 40(8 Pt 2):3016-7. PubMed ID: 7190464
[TBL] [Abstract][Full Text] [Related]
3. Alpha-human chorionic gonadotropin and neuron-specific enolase as markers for malignancy and neuroendocrine nature of pancreatic endocrine tumors.
Klöppel G; Girard J; Polak JM; Vaitukaitis JL; Kasper M; Heitz PU
Cancer Detect Prev; 1983; 6(1-2):161-6. PubMed ID: 6309383
[TBL] [Abstract][Full Text] [Related]
4. Does hCG or hCGβ play a role in cancer cell biology?
Iles RK; Delves PJ; Butler SA
Mol Cell Endocrinol; 2010 Nov; 329(1-2):62-70. PubMed ID: 20654692
[TBL] [Abstract][Full Text] [Related]
5. Effect of immunization against human chorionic gonadotropin (hCG) on transplantation of Yoshida ascitic tumour.
Bernardini A; Corbino N; Rapisarda Proto G; Iacona G; Stivala F
Microbiologica; 1982 Oct; 5(4):383-8. PubMed ID: 7154977
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free beta-subunit: tumor markers and tumor promoters.
Cole LA; Butler SA
J Reprod Med; 2008 Jul; 53(7):499-512. PubMed ID: 18720925
[TBL] [Abstract][Full Text] [Related]
7. 8-1A, a human monoclonal antibody that reacts with intact human chorionic gonadotropin.
Suzuki N; Aoki D; Orikawa K; Suzuki A; Susumu N; Tamada Y; Sakayori M; Tsukazaki K; Mukai M; Kikuchi H; Ishida I; Nozawa S
Placenta; 2006; 27(2-3):333-9. PubMed ID: 16338478
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of dose dependent cytotoxic activity in cancer cells by specific human chorionic gonadotropin monoclonal antibodies.
Kalantarov G; Acevedo HF
Cancer; 1998 Aug; 83(4):783-7. PubMed ID: 9708946
[TBL] [Abstract][Full Text] [Related]
9. Human chorionic gonadotropin and associated molecules.
Cole LA
Expert Rev Mol Diagn; 2009 Jan; 9(1):51-73. PubMed ID: 19099349
[TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal masses with associated human chorionic gonadotropin production: Report of two cases.
Duffield AS; Jarrar P; Shum C; Ahuja N; Yeo CJ; Sokoll LJ
Clin Chim Acta; 2008 Sep; 395(1-2):166-9. PubMed ID: 18505680
[TBL] [Abstract][Full Text] [Related]
11. [Persistent low levels of human chorionic gonadotropin in the serum: investigation and management].
Faranesh R; Ben-David Y
Harefuah; 2009 Feb; 148(2):101-3, 139. PubMed ID: 19627038
[TBL] [Abstract][Full Text] [Related]
12. Necrosis and inhibition of growth of human lung tumor by anti-alpha-human chorionic gonadotropin antibody.
Kumar S; Talwar GP; Biswas DK
J Natl Cancer Inst; 1992 Jan; 84(1):42-7. PubMed ID: 1371163
[TBL] [Abstract][Full Text] [Related]
13. The quagmire of hCG and hCG testing in gynecologic oncology.
Muller CY; Cole LA
Gynecol Oncol; 2009 Mar; 112(3):663-72. PubMed ID: 19007977
[TBL] [Abstract][Full Text] [Related]
14. Production of human chorionic gonadotropin during the normal menstrual cycle.
Cole LA; Gutierrez JM
J Reprod Med; 2009 Apr; 54(4):245-50. PubMed ID: 19438167
[TBL] [Abstract][Full Text] [Related]
15. "In vivo" anti-hCG antibodies and Yoshida's tumor development.
Mangano A; Bernardini A
J Immunopharmacol; 1983; 5(4):359-70. PubMed ID: 6668426
[TBL] [Abstract][Full Text] [Related]
16. [Immunological deficiencies associated with malignant gynecological tumors].
Laurentaci G; Maiorino R; Schonauer S; Favoino B; Loiudice L
Minerva Ginecol; 1980 Apr; 32(4):303-7. PubMed ID: 6966773
[No Abstract] [Full Text] [Related]
17. Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: a specific marker for malignancy. Immunocytochemical analysis of tumors of 155 patients.
Heitz PU; Kasper M; Klöppel G; Polak JM; Vaitukaitis JL
Cancer; 1983 Jan; 51(2):277-82. PubMed ID: 6821817
[TBL] [Abstract][Full Text] [Related]
18. Impact of female sex hormones on the maturation and function of human dendritic cells.
Segerer SE; Müller N; van den Brandt J; Kapp M; Dietl J; Reichardt HM; Rieger L; Kämmerer U
Am J Reprod Immunol; 2009 Sep; 62(3):165-73. PubMed ID: 19694642
[TBL] [Abstract][Full Text] [Related]
19. Effects of human chorionic gonadotropin on luteal blood flow and progesterone secretion in cows and in vitro-microdialyzed corpora lutea.
Beindorff N; Honnens A; Penno Y; Paul V; Bollwein H
Theriogenology; 2009 Sep; 72(4):528-34. PubMed ID: 19515407
[TBL] [Abstract][Full Text] [Related]
20. The immune system in gynecologic malignancies.
Barber HR; Dorsett BH
Mt Sinai J Med; 1980; 47(5):539-49. PubMed ID: 6969360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
